iTeos Therapeutics (ITOS)
NASDAQ:ITOS
US Market

iTeos Therapeutics (ITOS) Financial Statements

153 Followers

iTeos Therapeutics Financial Overview

iTeos Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.778; its P/E ratio is -4.42; iTeos Therapeutics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-1.04. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue----$ 343.00K
Gross Profit----$ 343.00K
EBIT$ -37.75M$ -28.19M$ -33.42M$ -33.07M$ -14.35M
EBITDA$ -37.45M$ -27.96M$ -33.20M$ -32.84M$ -14.13M
Net Income Common Stockholders$ -38.22M$ -30.55M$ -33.29M$ -34.30M$ -15.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 449.14M$ 531.92M$ 599.03M$ 599.22M$ 602.14M
Total Assets$ 629.77M$ 667.59M$ 677.64M$ 703.75M$ 728.35M
Total Debt$ 5.82M$ 6.06M$ 5.93M$ 5.45M$ 4.63M
Net Debt$ -443.32M$ -525.86M$ -593.10M$ -593.78M$ -597.51M
Total Liabilities$ 88.57M$ 92.36M$ 79.38M$ 80.22M$ 76.08M
Stockholders Equity$ 541.20M$ 575.23M$ 598.26M$ 623.53M$ 652.26M
Cash Flow-
Free Cash Flow$ -33.34M$ -15.18M$ -34.72M$ -30.25M$ -26.67M
Operating Cash Flow$ -32.40M$ -13.77M$ -33.89M$ -29.55M$ -26.55M
Investing Cash Flow$ -69.60M$ 61.56M$ 22.69M$ 20.10M$ -31.69M
Financing Cash Flow$ 22.00K$ 307.00K$ 10.00K$ 218.00K$ 578.00K
Currency in USD

iTeos Therapeutics Earnings and Revenue History

iTeos Therapeutics Debt to Assets

iTeos Therapeutics Cash Flow

iTeos Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis